MALAT1 is a prognostic factor in glioblastoma multiforme and induces chemoresistance to temozolomide through suppressing miR-203 and promoting thymidylate synthase expression.
about
LncRNA FENDRR sensitizes doxorubicin-resistance of osteosarcoma cells through down-regulating ABCB1 and ABCC1.Long noncoding RNA MALAT1 promotes cell proliferation through suppressing miR-205 and promoting SMAD4 expression in osteosarcoma.Ginkgo biloba extract EGb 761-induced upregulation of LincRNA-p21 inhibits colorectal cancer metastasis by associating with EZH2.Targeted nanocomplex carrying siRNA against MALAT1 sensitizes glioblastoma to temozolomide.Nuclear Long Noncoding RNAs: Key Regulators of Gene Expression.Chronic oxymatrine treatment induces resistance and epithelial‑mesenchymal transition through targeting the long non-coding RNA MALAT1 in colorectal cancer cells.Splicing regulation by long noncoding RNAs.MALAT1/miR-101-3p/MCL1 axis mediates cisplatin resistance in lung cancer.Multiple treatment modalities for brain metastasis in patients with EGFR-mutant non-small-cell lung cancer.Metastasis-associated lung adenocarcinoma transcript 1 regulates tumor progression: old wine in a new bottle.MALAT1: a druggable long non-coding RNA for targeted anti-cancer approaches.Targeting Long Noncoding RNA in Glioma: A Pathway PerspectiveClinicopathological and prognostic significance of long noncoding RNA MALAT1 in human cancers: a review and meta-analysis
P2860
Q42654010-5392F8E6-49E9-4FF4-93A1-07D7D03EF91BQ47119874-039ADE4C-86E9-4732-A0B1-C304726D8DB2Q47146370-2E209ED1-F469-4214-9FB9-D2F4588A0E6DQ47935571-71138F8B-7B03-4309-8824-8278E28A69E2Q49715418-FBB32026-799D-4D69-92B3-4FCE266BC4C2Q50068000-72785FFA-C1E2-4FAD-9B83-959F7E1025CBQ50098862-255A8FC5-23A8-4A86-B9E7-ED9B9C3A885AQ50354652-B3064095-066A-468C-BB24-949A8D35FCA2Q54113349-851F656B-6162-4C6C-9A80-990CA7243C46Q55161480-9043BD37-AF8D-4919-8196-3C15B0B56A26Q55245371-F4AE4494-906B-424A-B5B8-F74DEF37C3EAQ58587329-D53363D6-CC7C-446B-B9D5-C329F13338B4Q58799464-A37E8D93-9CCA-4740-8410-CEEEB692C632
P2860
MALAT1 is a prognostic factor in glioblastoma multiforme and induces chemoresistance to temozolomide through suppressing miR-203 and promoting thymidylate synthase expression.
description
2017 nî lūn-bûn
@nan
2017 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2017 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2017年の論文
@ja
2017年論文
@yue
2017年論文
@zh-hant
2017年論文
@zh-hk
2017年論文
@zh-mo
2017年論文
@zh-tw
2017年论文
@wuu
name
MALAT1 is a prognostic factor ...... ymidylate synthase expression.
@ast
MALAT1 is a prognostic factor ...... ymidylate synthase expression.
@en
type
label
MALAT1 is a prognostic factor ...... ymidylate synthase expression.
@ast
MALAT1 is a prognostic factor ...... ymidylate synthase expression.
@en
prefLabel
MALAT1 is a prognostic factor ...... ymidylate synthase expression.
@ast
MALAT1 is a prognostic factor ...... ymidylate synthase expression.
@en
P2093
P2860
P356
P1433
P1476
MALAT1 is a prognostic factor ...... ymidylate synthase expression.
@en
P2093
Cheng Chen
Fang-Cheng Li
Fangyu Wang
Jun-Liang Li
Kuan-Kei Kong
Xiao-Song Ge
P2860
P304
22783-22799
P356
10.18632/ONCOTARGET.15199
P407
P577
2017-02-08T00:00:00Z